Health & Pharm General

Oventus Medical Ltd (ASX:OVN) $2.95 Million Grant Successful in Latest CRC-P Funding Round

🕔2/8/2017 1:54:55 PM

Oventus Medical Limited (ASX:OVN) today announced that it is the lead participant in a successful application for a grant in the 2nd round of the CRC-P grants that from the Australian Federal Government. The project will receive $2,950,000 over three years for a project titled, "Targeted therapy for sleep apnoea: A novel personalised approach".

Read Full Article

Immuron Limited (ASX:IMC) Announces First Patient Enrolled in Pediatric Fatty-Liver Phase II Trial

🕔2/7/2017 9:00:32 AM

Immuron Limited (ASX:IMC) (OTCMKTS:IMROY), an Australian biopharmaceutical company focused on oral immunotherapy utilizing polyclonal antibody products to target inflammatory-mediated diseases, today announced that Emory University has enrolled its first patient in Immuron's IMM-124E pediatric NAFLD Phase II trial.

Read Full Article

Lifespot Health Ltd (ASX:LSH) Enters New Market Segment of Coagulation Home Monitoring

🕔2/3/2017 2:39:21 PM

Lifespot Health Ltd (ASX:LSH) is pleased to announce that its 100% owned subsidiary, BodyTel GmbH and Roche Diagnostics Deutschland GmbH, have signed an agreement to integrate Roche's newly developed Bluetooth enabled PT/INR device 'CoaguChek(R) INRange' into BodyTel's telemedical platform.

Read Full Article

YPB Group Ltd (ASX:YPB) Updated Outlook for 2017

🕔2/2/2017 10:41:06 AM

Brand Protection and Customer Engagement solutions company YPB Group Ltd (ASX:YPB) is pleased to provide an updated outlook for 2017. YPB has concluded its Annual Operating Plan process, reconfirming the expectation of a $5m pretax profit for the year to December 2017.

Read Full Article

YPB Group Ltd (ASX:YPB) Company Update and Appendix 4C

🕔2/1/2017 9:32:04 AM

Brand Protection and Customer Engagement solutions company YPB Group Ltd (ASX:YPB) is pleased to provide a summary of activities for the quarter ended 31 December 2016.

Read Full Article

MMJ PhytoTech Ltd (ASX:MMJ) Quarterly Update

🕔2/1/2017 9:31:02 AM

MMJ PhytoTech Ltd (ASX:MMJ) is pleased to provide its quarterly activities report for the period ended 31 December 2016.

Read Full Article

MMJ PhytoTech Ltd (ASX:MMJ) Announces Harvest One (CVE:WON.H) to Increase Equity Raising to C$25M

🕔1/30/2017 1:07:55 PM

MMJ PhytoTech (ASX:MMJ) is pleased to advise that Canadian-based Harvest One Capital Corp. (CVE:WON.H) has increased its private placement to C$22 million, plus an over-allotment option of up to an additional C$3 million. Under the increased offering, Harvest One may issue up to 33,333,333 subscription receipts at a price of $0.75 per Subscription Receipt.

Read Full Article